Adults living with obesity or overweight who do not have type 2 diabetes may qualify for a research study evaluating an investigational once-weekly injectable medication for weight management.
Adults living with obesity or overweight who do not have type 2 diabetes may qualify for a research study evaluating an investigational once-weekly injectable medication for weight management.
The purpose of this study is to better understand how well the investigational treatment works in reducing body weight, improving weight-related health measures, and evaluating its safety and tolerability. Researchers will also study how the investigational medication may affect blood sugar levels, cholesterol, blood pressure, body composition, and quality of life.
You may be able to join if you:
-Are at least 18 years of age
-Have obesity with a body mass index (BMI) of 30 or greater
OR have overweight with a BMI of 27 or greater and at least one weight-related medical condition
-Have a history of at least one unsuccessful dietary effort to reduce body weight
-Do not have type 2 diabetes
Adults with osteoarthritis (OA) knee pain may qualify for a research study evaluating an investigational medication for chronic pain relief.
Adults 18 to 75 years of age may qualify for a research study evaluating an investigational medication for migraine attacks.
Adults ages 18 to 70 who experience episodic migraine may qualify for a clinical research study evaluating an investigational medication […]
Adults 18 years and older may qualify for a study evaluating investigational treatment options for diabetic peripheral neuropathic pain (DPNP), […]
Adults 18 years and older may qualify for a study evaluating an investigational oral study medication for elevated lipoprotein(a) [Lp(a)], […]
Adults living with obesity or overweight who do not have type 2 diabetes may qualify for a research study evaluating […]